NASDAQ:OLMA 18 November 2025

OLMA stock jumps 10% into JPMorgan week — what to watch for Olema Pharmaceuticals

Olema Pharmaceuticals Inc shares closed up 9.8% on Friday at $28.08, with about 2.5 million shares changing hands, as investors headed into a catalyst-heavy week for the cancer drug developer.

11 January 2026

NASDAQ:OLMA·Pharmaceuticals

Olema Pharmaceuticals (OLMA) Stock: Weekend Read Ahead on the Pullback, Insider Sales, and Wall Street Targets Before Monday’s Open

Olema Pharmaceuticals, Inc. heads into the final trading days of 2025 with investors trying to separate two very different realities: an explosive year-to-date run that put the breast-cancer biotech firmly on the growth-stock map—and a sharp late-December pullback that has reset near-term expectations.

28 December 2025

NASDAQ:OLMA·Pharmaceuticals·Stock Market

Olema Pharmaceuticals (OLMA) Stock Update: Weekend Snapshot, Insider Sales, Analyst Targets, and Key Catalysts Ahead of Monday

Olema Pharmaceuticals, Inc. is heading into the weekend with investors weighing a sharp Friday pullback against a still-staggering multi-month run, a cluster of insider-trading filings, and a set of analyst price targets that continue to imply significant upside—if Olema’s late-stage breast cancer program delivers on its timeline.

28 December 2025

NASDAQ:OLMA

Olema Pharmaceuticals (NASDAQ: OLMA) Stock: Latest News, Analyst Forecasts, and What’s Driving the Volatility on December 19, 2025

Olema Pharmaceuticals, Inc. trades under the ticker OLMA on Nasdaq. GlobeNewswire+1 On Friday, December 19, 2025, the stock was sharply lower intraday—$28.89, down $1.92 at the latest published trade time in the market data feed, after opening $31.22 and swinging between $31.95 and $28.89.

19 December 2025

Financial Forecasts·NASDAQ:OLMA·Pharmaceuticals·Stock Market

Olema Pharmaceuticals (OLMA) Stock Hits New 52‑Week High on December 10, 2025: What Investors Need to Know

Olema Pharmaceuticals, Inc., which now brands itself as Olema Oncology, is having another breakout session on December 10, 2025.

10 December 2025

NASDAQ:OLMA·Pharmaceuticals

Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025

Olema Pharmaceuticals, Inc. has quietly turned into one of 2025’s wilder biotech stories: a tiny oncology name that’s run more than eightfold off its 52-week low, pulled back on a big equity raise, and now sits in the middle of a high-stakes bet on a single breast-cancer drug.

9 December 2025

NASDAQ:OLMA·Pharmaceuticals·Stock Market

Olema Pharmaceuticals (OLMA) Soars Over 200% After Roche Breast Cancer Trial Win — What It Means for Palazestrant and Investors on November 18, 2025

Olema Pharmaceuticals didn’t publish a press release or file anything with the SEC this morning. Yet, its stock rocketed nearly threefold in pre‑market trading on Tuesday, November 18, 2025. TipRanks+1

18 November 2025

Biotechnology·NASDAQ:OLMA·NYSE:PFE·Pharmaceuticals·Stock Market·SWX:ROG.SW

OLMA stock jumps 10% into JPMorgan week — what to watch for Olema Pharmaceuticals

Olema Pharmaceuticals (OLMA) Stock: Weekend Read Ahead on the Pullback, Insider Sales, and Wall Street Targets Before Monday’s Open

Olema Pharmaceuticals (OLMA) Stock Update: Weekend Snapshot, Insider Sales, Analyst Targets, and Key Catalysts Ahead of Monday

Olema Pharmaceuticals (NASDAQ: OLMA) Stock: Latest News, Analyst Forecasts, and What’s Driving the Volatility on December 19, 2025

Olema Pharmaceuticals (OLMA) Stock Hits New 52‑Week High on December 10, 2025: What Investors Need to Know

Olema Pharmaceuticals (OLMA) Stock: Latest News, Forecast & Analysis as of December 9, 2025

Olema Pharmaceuticals (OLMA) Soars Over 200% After Roche Breast Cancer Trial Win — What It Means for Palazestrant and Investors on November 18, 2025

TechStock² Updates

Nu Stock Falls 3.9%, Erasing $2.8 Billion as 6.9% NPL Rate Tests Credit Growth

Nokia Shares Drop 3.6%, Wiping Out $2.2 Billion as Rate Concerns Pressure 26x Earnings Multiple

UiPath Shares Edge Down 1.0% as Options Market Expects 11% Post-Earnings Move

American Airlines Shares Fall 0.6% While Carrier Adds Seven Routes, Faces 2.7% Operating Margin Pressure

PayPal Stock Falls 12.7%, Erasing $6.9 Billion as $53 Billion Bid Collapses

Circle’s $73.7 Billion USDC Gains International Visibility With Chelsea Shirt Sponsorship

Marvell Shares Drop 10.3%, Wiping Out $22 Billion After Google AI Revenue Delayed Beyond 2029

Ondas Shares Drop 9.7% After Reporting $50.6 Million EBITDA Loss Despite $757 Million Backlog

IREN shares drop 12.5% after $4 billion AI contract announcements coincide with $703 million annual loss

Nvidia Stock Falls 4.6%, Erasing $251 Billion as Margin Guide Tests AI Rally

Investment Disclaimer